PatientsVille.com Logo

PatientsVille

Pantecta Side Effects

Common Pantecta Side Effects


The most commonly reported Pantecta side effects (click to view or check a box to report):

Death (7)
Wheezing (4)
Gastrointestinal Haemorrhage (4)
Fall (3)
Chest Discomfort (3)
Rib Fracture (3)
Osteoporosis (3)
Renal Failure (2)
Hiatus Hernia (2)
Nausea (2)
Ulcer (2)
Hepatic Failure (2)
Urticaria (2)
Bone Densitometry (2)
Anaemia (2)
Colon Cancer (2)
Bronchospasm (2)
Cardiac Failure (2)
Dengue Fever (2)
Haemorrhage (2)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Pantecta Side Effects Reported to FDA

The following Pantecta reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Pantecta on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Hypokalaemia, Hypomagnesaemia
This is a report of a 89-year-old female patient (weight: NA) from ES, suffering from the following symptoms/conditions: NA, who was treated with Pantecta (dosage: NA, start time: 2013), combined with: NA. and developed a serious reaction and side effect(s). The consumer presented with:
  • Hypokalaemia
  • Hypomagnesaemia
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Pantecta treatment in female patients, resulting in hypokalaemia side effect.

Ocular Hyperaemia, Pruritus
This report suggests a potential Pantecta Ocular Hyperaemia, Pruritus side effect(s) that can have serious consequences. A 40-year-old male patient (weight: NA) from CR was diagnosed with the following symptoms/conditions: gastritis and used Pantecta (dosage: 40 Mg, 1x/day) starting Aug 01, 2013. Soon after starting Pantecta the patient began experiencing various side effects, including:
  • Ocular Hyperaemia
  • Pruritus
Drugs used concurrently: NA. Although Pantecta demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as ocular hyperaemia, may still occur.

Syncope, Off Label Use
This Syncope, Off Label Use problem was reported by a physician from ITALY. A 40-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On Aug 22, 2008 this consumer started treatment with Pantecta (dosage: NA). The following drugs were being taken at the same time:
  • Lasix
  • Mabthera
  • Medrol
  • Calcium Carbonate/colecalciferol
  • Ketorolac Tromethamine
  • Arthrotec
When commencing Pantecta, the patient experienced the following unwanted symptoms/side effects:
  • Syncope
  • Off Label Use
The patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as syncope, may become evident only after a product is in use by the general population.

Metastases To Lung, Ovarian Cancer
This is a report of a 49-year-old female patient (weight: NA) from GUATEMALA. The patient developed the following symptoms/conditions: irritable bowel syndrome and was treated with Pantecta (dosage: 20 Mg, Unk) starting NS. Concurrently used drugs: NA.Soon after that, the consumer experienced the following side effects:
  • Metastases To Lung
  • Ovarian Cancer
This opens a possibility that Pantecta treatment could cause the above reactions, including metastases to lung, and some female subjects may be more susceptible.


Neoplasm Malignant
A 81-year-old female patient (weight: NA) from GUATEMALA with the following symptoms/conditions: NA started Pantecta treatment (dosage: 40 Mg, Unk) on NS. Soon after starting Pantecta treatment, the subject experienced various side effects, including:
  • Neoplasm Malignant
Concurrently used drugs: NA. This finding indicates that some female patients could be more vulnerable to Pantecta.


A 67-year-old female patient from EL SALVADOR (weight: NA) experienced symptoms, such as: NA and was treated with Pantecta(dosage: Unk). The treatment was initiated on NS. After that a consumer reported the following side effect(s):
    Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Pantecta efficacy: NA.


    In this report, Pantecta was administered for the following condition: NA.A 76-year-old female consumer from EL SALVADOR (weight: NA) started Pantecta treatment (dosage: 40 Mg, Unk) on NS.Sometime after starting the treatment, the patient complained of the following side effect(s):
      A possible interaction with other drugs could have contributed to this reaction: NA.Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Pantecta treatment could be related to the listed above side effect(s).


      This is a report of the following Pantecta side effect(s):
        A 69-year-old male patient from EL SALVADOR (weight: NA) presented with the following condition: NA and received a treatment with Pantecta (dosage: 40 Mg, Unk) starting: NS.The following concurrently used drugs could have generated interactions: NA.This report suggests that a Pantecta treatment could be associated with the listed above side effect(s).


        This Pantecta report was submitted by a 67-year-old female consumer from EL SALVADOR (weight: NA). The patient was diagnosed with: NA and Pantecta was administered (dosage: Unk) starting: NS. The consumer developed a set of symptoms:
          Other drugs used simultaneously: NA.Those unexpected symptoms could be linked to a Pantecta treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

          Wheezing, Chest Discomfort
          This is a report of a possible correlation between Pantecta use and the following symptoms/side effect(s):
          • Wheezing
          • Chest Discomfort
          which could contribute to an assessment of Pantecta risk profile.A 80-year-old female consumer from JAMAICA (weight: NA) was suffering from dyspepsia and was treated with Pantecta (dosage: 40 Mg, Unk) starting Jan 14, 2011.Other concurrent medications:
          • Baralgin (1000 Mg, Unk)


          Wheezing, Chest Discomfort
          A 80-year-old female patient from JAMAICA (weight: NA) presented with the following symptoms: dyspepsia and after a treatment with Pantecta (dosage: 40 Mg, Unk) experienced the following side effect(s):
          • Wheezing
          • Chest Discomfort
          The treatment was started on Jan 14, 2011. Pantecta was used in combination with the following drugs:
          • Baralgin (1000 Mg, Unk)
          This report could alert potential Pantecta consumers.

          Chest Discomfort, Wheezing
          In this report, a 80-year-old female patient from JAMAICA (weight: NA) was affected by a possible Pantecta side effect.The patient was diagnosed with NA. After a treatment with Pantecta (dosage: Unk, start date: Jan 14, 2011), the patient experienced the following side effect(s):
          • Chest Discomfort
          • Wheezing
          The following simultaneously used drugs could have led to this reaction:
          • Baralgin (Unk)
          The findings here stress that side effects should be taken into consideration when evaluating a Pantecta treatment.

          Headache, Vomiting, Loss Of Consciousness, Vertigo, Myalgia, Nausea
          This is a report of a 47-year-old female patient from SPAIN (weight: NA), who used Pantecta (dosage: NA) for a treatment of NA. After starting a treatment on Jun 01, 2009, the patient experienced the following side effect(s):
          • Headache
          • Vomiting
          • Loss Of Consciousness
          • Vertigo
          • Myalgia
          • Nausea
          The following drugs could possibly have interacted with the Pantecta treatment
          • Baraclude (One Year Ago In May 2010 Dose Changed To 1mg/d)
          • Sedotime
          • Ibuprofen
          • Lexatin
          The patient was hospitalized.Taken together, these observations suggest that a Pantecta treatment could be related to side effect(s), such as Headache, Vomiting, Loss Of Consciousness, Vertigo, Myalgia, Nausea.

          Penile Ulceration
          This penile ulceration side effect was reported by a health professional from GUATEMALA. A 54-year-old male patient (weight:NA) experienced the following symptoms/conditions: gastritis,gastrooesophageal reflux disease. The patient was prescribed Pantecta (dosage: 40 Mg, Unk), which was started on NS. Concurrently used drugs: NA. When starting to take Pantecta the consumer reported the following symptoms:
          • Penile Ulceration
          These side effects may potentially be related to Pantecta.

          Nausea, Respiratory Distress, Wheezing
          This is a Pantecta side effect report of a 35-year-old male patient (weight:NA) from JAMAICA, suffering from the following symptoms/conditions: gastritis, who was treated with Pantecta (dosage:NA, start time: Jul 23, 2010), combined with: NA., and developed a serious reaction and a nausea side effect. The patient presented with:
          • Nausea
          • Respiratory Distress
          • Wheezing
          which developed after the beginning of treatment. This side effect report can indicate a possible existence of increased vulnerability to Pantecta treatment in male patients suffering from gastritis, resulting in nausea.


          This report suggests a potential Pantecta death side effect(s) that can have serious consequences. A 83-year-old male patient from GUATEMALA (weight:NA) was diagnosed with the following health condition(s): NA and used Pantecta (dosage: NA) starting NS. Soon after starting Pantecta the patient began experiencing various side effects, including:
            Drugs used concurrently:NA. Although Pantecta demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as death, may still occur.

            Caesarean Section
            This caesarean section problem was reported by a health professional from GUATEMALA. A 30-year-old female patient (weight: NA) was diagnosed with the following medical condition(s): peptic ulcer.On Jan 01, 2008 a consumer started treatment with Pantecta (dosage: NA). The following drugs/medications were being taken at the same time:
            • Glibenclamide
            • Levothyroxine Sodium
            When commencing Pantecta, the patient experienced the following unwanted symptoms /side effects:
            • Caesarean Section
            Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as caesarean section, may become evident only after a product is in use by the general population.

            Parotitis
            This is a Pantecta side effect report of a 52-year-old female patient (weight: NA) from SPAIN. The patient developed the following symptoms/conditions: prophylaxis and was treated with Pantecta (dosage: NA) starting Nov 04, 2009. Concurrently used drugs:
            • Polaramine
            • Mabthera
            • Perfalgan
            • Hydrocortisone Sodium Phosphate
            • Adiro
            Soon after that, the consumer experienced the following of symptoms:
            • Parotitis
            This opens a possibility that Pantecta could cause parotitis and that some female patients may be more susceptible.

            Hernia Repair
            A 60-year-old female patient (weight: NA) from GUATEMALA with the following symptoms: NA started Pantecta treatment (dosage: NA) on NS. Soon after starting Pantecta treatment, the consumer experienced several side effects, including:
            • Hernia Repair
            . Concurrently used drugs: NA. This finding indicates that some patients can be more vulnerable to developing Pantecta side effects, such as hernia repair.

            Abdominal Mass
            This abdominal mass side effect was reported by a consumer or non-health professional from GUATEMALA. A 74-year-old female patient (weight:NA) experienced the following symptoms/conditions: gastritis.The patient was prescribed Pantecta (dosage: NA), which was started on Mar 01, 2009. Concurrently used drugs:
            • Sucralfate
            • Vitamins Nos
            • Metoclopramide
            .When starting to take Pantecta the consumer reported symptoms, such as:
            • Abdominal Mass
            These side effects may potentially be related to Pantecta.

            Anaemia, Bronchitis Bacterial, Bronchospasm, Cardiac Failure, Condition Aggravated, Immunosuppression, Influenza, Leukocytosis
            This is a report of a 77-year-old male patient (weight: NA) from COSTA RICA, suffering from the following symptoms/conditions: gastrointestinal haemorrhage,anaemia, who was treated with Pantecta (dosage: NA, start time: Jan 01, 2009), combined with:
            • Blood And Related Products
            • Iron
            • Enalapril Maleate
            • Digoxin
            and developed a serious reaction and side effect(s). The consumer presented with:
            • Anaemia
            • Bronchitis Bacterial
            • Bronchospasm
            • Cardiac Failure
            • Condition Aggravated
            • Immunosuppression
            • Influenza
            • Leukocytosis
            which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Pantecta treatment in male patients, resulting in anaemia side effect.

            Cerebral Infarction, Transient Ischaemic Attack
            This report suggests a potential Pantecta Cerebral Infarction, Transient Ischaemic Attack side effect(s) that can have serious consequences. A 82-year-old female patient (weight: NA) from GERMANY was diagnosed with the following symptoms/conditions: dyspepsia,back pain and used Pantecta (dosage: NA) starting Feb 01, 2008. Soon after starting Pantecta the patient began experiencing various side effects, including:
            • Cerebral Infarction
            • Transient Ischaemic Attack
            Drugs used concurrently:
            • Acrel Semanal
            • Artilog
            • Hyzaar
            • Cardyl
            Although Pantecta demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as cerebral infarction, may still occur.

            Haemolytic Anaemia
            This Haemolytic Anaemia problem was reported by a health professional from GERMANY. A 69-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: dyspepsia,osteoarthritis. On May 08, 2008 this consumer started treatment with Pantecta (dosage: NA). The following drugs were being taken at the same time:
            • Arcoxia
            When commencing Pantecta, the patient experienced the following unwanted symptoms/side effects:
            • Haemolytic Anaemia
            The patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as haemolytic anaemia, may become evident only after a product is in use by the general population.

            Acute Pulmonary Oedema, Cardiac Failure, Diabetes Mellitus, Myocardial Infarction, Renal Failure Chronic
            This is a report of a 78-year-old male patient (weight: NA) from COSTA RICA. The patient developed the following symptoms/conditions: dyspepsia,colitis and was treated with Pantecta (dosage: NA) starting Jan 01, 2009. Concurrently used drugs: NA.Soon after that, the consumer experienced the following side effects:
            • Acute Pulmonary Oedema
            • Cardiac Failure
            • Diabetes Mellitus
            • Myocardial Infarction
            • Renal Failure Chronic
            The patient was hospitalized. This opens a possibility that Pantecta treatment could cause the above reactions, including acute pulmonary oedema, and some male subjects may be more susceptible.

            Pancreatic Carcinoma
            A 81-year-old female patient (weight: NA) from COSTA RICA with the following symptoms/conditions: NA started Pantecta treatment (dosage: NA) on NS. Soon after starting Pantecta treatment, the subject experienced various side effects, including:
            • Pancreatic Carcinoma
            Concurrently used drugs:
            • Tramadol Hcl
            This finding indicates that some female patients could be more vulnerable to Pantecta.

            1 of 2 



            Top 10 Pantecta Side Effects for Women

            Women Side EffectsReports
            Death 5
            Chest Discomfort 3
            Fall 3
            Osteoporosis 3
            Rib Fracture 3
            Wheezing 3
            Bone Densitometry 2
            Dengue Fever 2
            Hepatic Failure 2
            Renal Failure 2

            Top 10 Pantecta Side Effects for Men

            Men Side EffectsReports
            Gastrointestinal Haemorrhage 4
            Anaemia 2
            Bronchospasm 2
            Cardiac Failure 2
            Colon Cancer 2
            Death 2
            Haemorrhage 2
            Hiatus Hernia 2
            Neutropenia 2
            Ulcer 2

            Keep Track of Side Effects

            Note Your Observations

            It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

            Why Your Notes are Important

            Your notes could be helpful in several ways:

          • You can use them to remind you of details that may alert your health care professional(s) to a problem
          • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

          • Log Form

            You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

            Medicine Name and Dosage:
            Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
            Scale: 1 = very mild to 10 = very bad

            You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


            Discuss Pantecta Side Effects

            Did You Have a Pantecta Side Effect?

            Yes, Severe
            Yes, Moderate
            Yes, Minor
            No

            How Effective is Pantecta for You?

            Exceeded Expectations
            Effective
            Somewhat Effective
            Not Effective

            Pantecta Safety Alerts, Active Ingredients, Usage Information

            More About Pantecta

            Side Effects reported to FDA: 46

            Pantecta safety alerts: No

            Reported deaths: 22

            Reported hospitalizations: 11

            Latest Pantecta clinical trials